首页> 外国专利> still for framstellning of new part? 728. 72 (? 729. 72) - steroidderivat tillhorande pregnanserien

still for framstellning of new part? 728. 72 (? 729. 72) - steroidderivat tillhorande pregnanserien

机译:还在为新部分做些微词吗? 728.72(?729.72)-甾体除草剂horhorande pregnanserien

摘要

1440064 ASP8(9)/SP-Steroids of the pregnane series GLAXO LABORATORIES Ltd 10 Aug 1973 [11 Aug 1972] 37656/72 Heading C2U [Also in Division A5] Novel steroids of the formula wherein R 1 is -COC 2 H 5 or -COC 3 H 7 (n- or iso-) and R 2 is H, -COCH 3 , -COC 2 H 5 or -COC 3 H 7 (n- or iso-) are prepared (1) by dehydrohalogenation of steroids of the formula (wherein X is Cl or Br) which may in turn be prepared by addition of HOX to the corresponding 9,11-unsubstituted-#SP9(11)/SP-steroids; or (2) by conversion of corresponding 17 ,21-diols to ortho-esters by reaction with RSP1/SPC(0RSP11/SP) 3 wherein RSP1/SP is C 2 H 5 , n-C 3 H 7 or iso-C 3 H 7 and RSP11/SP is C 1-4 alkyl followed by hydrolysis to give 17- acyloxy-21-ols as products which may subsequently be 21-acylated. Starting materials corresponding to the first structural formula above but containing a free 17-OH group are prepared by method (1) above using a free 17-ol starting material. 11#,17,21- Trihydroxy - 16# - methylpregna - 1,4,8(9)- triene-3,20-dione is prepared by hydrolysis of the corresponding 21-acetate. 16#-Methyl- 17 ,21 - dipropionylocypregna - 1,4,9(11) - triene - 3,20- dione is prepared by acylation of the corresponding 21-ol. The corresponding 21-acetate is prepared similarly. 9-Bromo- 11#-hydroxy- 16# - methyl - 17 ,21 - dipropionyloxypregna- 1,4-diene-3,20-dione is also prepared similarly. The novel steroids are anti-inflammatory agents and may be made up into pharmaceutical compositions with suitable carriers (see Division A5).
机译:1440064 A 8(9)-孕烷系列的类固醇GLAXO LABORATORIES Ltd 1973年8月10日[1972年8月11日]标题C2U [也在A5分部中]其中R 1为下式的新型类固醇制备-COC 2 H 5或-COC 3 H 7(n-或异-),且R 2为H,制备-COCH 3,-COC 2 H 5或-COC 3 H 7(n-或异-)(1 ),通过式(Ⅰ中X是Cl或Br)的类固醇的脱卤化氢反应,可以通过将HOX加到相应的9,11-未取代的-# 9(11)-类固醇上而制得;或(2)通过与R 1 C(0R 11 )3反应将相应的17,21-二醇转化为原酸酯,其中R 1 为C 2 H 5,nC 3 H 7或异-C 3 H 7,R 11 为C 1-4烷基,然后水解得到17-酰氧基-21-醇,其产物随后可以被21-酰化。对应于以上第一结构式但包含游离17-OH基团的起始原料使用游离的17-ol起始原料通过以上方法(1)制备。通过水解相应的21-乙酸酯制备11#,17,21-三羟基-16#-甲基孕烯-1,4,8(9)-三烯-3,20-二酮。通过将相应的21-ol酰化来制备16#-甲基-17,21-二丙炔基戊酸酯-1,4,9(11)-三烯-3,20-二酮。类似地制备相应的21-乙酸酯。同样地,也可以制备9-溴-11#-羟基-16#-甲基-17,21-二丙酰氧基孕烯-1,4-二烯-3,20-二酮。新型类固醇是抗炎药,可以与合适的载体制成药物组合物(请参阅A5部分)。

著录项

  • 公开/公告号SE396952B

    专利类型

  • 公开/公告日1977-10-10

    原文格式PDF

  • 申请/专利权人 * GLAXO LABORATORIES LTD;

    申请/专利号SE19730010984

  • 发明设计人 G H * PHILLIPPS;P J * MAY;

    申请日1973-08-10

  • 分类号C07J5/00;

  • 国家 SE

  • 入库时间 2022-08-23 00:42:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号